Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
|Articles|July 16, 2020
Controlling abnormal uterine bleeding in adolescents with levonorgestrel IUDs
Author(s)Lindsey Carr, Editor
New research suggests levonorgestrel IUDs are successful in treating adolescents with HMB and AUB.
Advertisement
A new study evaluated adolescents age 8 to 19 years and found that the levonorgestrel intrauterine device (IUD) is successful in controlling abnormal uterine bleeding (AUB) and suppressing menses. Of the patients studied, all used IUDs for contraception, management of heavy menstrual bleeding (HMB), and/or menstrual suppression.
For details on this study and an in-depth explanation of its findings, read the full article from
Advertisement
Related to this article
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
In September, the FDA accepted an extended duration sNDA for the IUD with a decision expected in Q2 2027.
In the debut episode of Missed & Dismissed, Calbeth C. Alaribe, DMSc, MPH, PA-C, CPCHE, talks with Charis Chambers, MD, about PCOS, the push to rename it PMOS, and why diagnostic delays so often begin in adolescence.
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Stephanie S. Faubion, MD, on choosing between fezolinetant and elinzanetant, liver monitoring, follow-up, and open questions in menopause care.
NK receptor antagonists significantly improved sleep disturbance in menopausal women at 4, 12, and 24 weeks in a meta-analysis of RCTs.
Perimenopausal women who were more physically active had significantly lower symptom burden across all domains, a study of 1808 Flo app users found.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Before Pregnancy Begins: Why the Timing of Carrier Screening Matters
2
JoAnn V. Pinkerton, MD, MSCP, on elinzanetant across menopause subpopulations at TMS 2026
3
Brain fog at menopause: Separating normal change from dementia
4
What to expect at The Menopause Society's 2026 Annual Meeting
5